Tataurova T A, Krepkova L V, Bortnikova V V, Kuznetsova Iu B, Eniutina E Iu
Farmakol Toksikol. 1988 Nov-Dec;51(6):87-90.
A preclinical study of safety of a plant preparation glyciram was carried out. At a single administration to laboratory animals the preparation is virtually a nontoxic compound. Intragastric administration of glyciram for 6 months in doses of 100 and 250 mg/kg may produce in animals functional changes of the liver and kidneys, which one should take into consideration when prescribing the preparation to patients suffering from diseases of these organs. The use of glyciram in doses of from 10 to 250 mg/kg causes no remote consequences--allergic, immunodepressive reactions, embryo-toxic, teratogenic and mutagenic effects.
对一种植物制剂glyciram进行了安全性的临床前研究。单次给予实验动物该制剂时,它实际上是一种无毒化合物。以100和250毫克/千克的剂量对动物进行6个月的胃内给药,可能会使动物的肝脏和肾脏出现功能变化,在给患有这些器官疾病的患者开这种制剂时应考虑到这一点。以10至250毫克/千克的剂量使用glyciram不会产生远期后果——过敏、免疫抑制反应、胚胎毒性、致畸和致突变作用。